Malaria transmission and status of drug resistance;TRANSMISSION HUMAINE ET RESISTANCE DES PLASMODIES

Revue du Praticien

Volumn 48, Issue 3, 1998, Pages 258-263

  Le Bras, Jacques ^a   Longuet, Christophe ^a   Charmot, Guy ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; ATOVAQUONE; CHLOROQUINE; CYCLOGUANIL; DAPSONE; HALOFANTRINE; MEFLOQUINE; PROGUANIL; PYRIMETHAMINE; QUININE; SULFADOXINE; SULFALENE; ANTIMALARIAL AGENT;

DISEASE TRANSMISSION; HUMAN; MALARIA; MUTATION; PLASMODIUM FALCIPARUM; SHORT SURVEY; SOCIOECONOMICS; TROPICS; AFRICA; ASIA; DRUG RESISTANCE; PARASITOLOGY; REVIEW; TROPIC CLIMATE;

AFRICA; ANTIMALARIALS; ASIA; DRUG RESISTANCE; HUMANS; MALARIA; TROPICAL CLIMATE;

EID: 0032007318     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (15)

1. Anonyme. La situation du paludisme dans le monde en 1993. Relevé épidémiologique hebdomadaire de l'OMS, 1996; 71: 17-48.
2. Mouchet J, Carnevale P. Les vecteurs et la transmission. In: Danis M, Mouchet J (eds). Paludisme. Paris: Ellipses, 1991: 35-59.
3. Mouchet J, Robert V, Carnevale P et al. Le défi de la lutte contre le paludisme en Afrique tropicale: place et limite de la lutte antivectorielle. Paris: Cahiers Santé, 1991; 1: 177-88.
4. Foley M, Tilley L Quinoline antimalarials: Mechanisms of action and resistance, Int J Parasitol 1997; 27: 231-40.
5. Borst P, Ouellette M. New mechanisms of drug resistance in parasitic protozoa. Ann Rev Microbiol 1995; 49: 427-60.
6. Basco LK, Le Bras J, Rhoades Z, Wilson CM. Analysis of pfMDRI and drug susceptibility in fresh isolates of P. falciparum from subsaharan Africa. Mol Biochem Parasitol 1995; 74: 157-66.
7. Su X, Kirkman LA, Wellems TE. Changes in genes from chromosome 7 of P. falciparum show high degree linkage of chloroquine responses. Am J Trop Med Hyg 1996; 55 S2: 242.
8. Wernsdorfer W, Payne D. The dynamics of drug resistance in P. falciparum. Pharm Ther 1991; 50: 95-121.
9. Cumming JN, Ploypradith P, Posner GH. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanisms of action. Adv Pharmacol 1997; 37: 253-97.
10. Looareesuwan S, Wilairatana P, Viravan S, Vanijanonta S, Pitisuttithum P, Kyle DE. Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria. Am J Trop Med Hyg 1997; 56: 613-7.
11. Wang P, Read M, Sims PFG, Hyde JE. Sulfadoxine resistance in the human malaria parasite P. falciparum is determined by mutations in dihydropteroate synthetase and a additional factor associated with folate utilization. Mol Microbiol 1997; 23: 979-86.
12. Sirawaraporn W, Sathitkul S, Sirawaraporn R, Yuthavong Y, Santi DV. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc Natl Acad Sci USA 1997; 94: 1124-9.
13. Durand R, Ramiliarisoa O, Secardin Y, de Pecoulas PE, Basco LK, Le Bras J. DHFR gene point mutation as a predictor of Plasmodium falciparum resistance to cycloguanil in malaria cases from Africa imported to France. Trans R Soc Trop Med Hyg 1997; 91: 460-1.
14. de Pecoulas PE, Basco LK, Le Bras J, Mazabraud A. Association between antifol resistance in vitro and DHFT point mutation in P. falciparum isolates. Trans R Soc Trop Med Hyg 1996; 90: 181-2.
15. Gassis S, Rathod PK. Frequency of drug resistance in P. falciparum: a nonsynergistic combination of 5-fluoroorotate and atovaquone suppresses in vitro resistance. Antimicrob Agents Chemother 1996; 40: 914-9.